Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Good News, Bad News On Medication Adherence: Problem Understood, Now How To Fix Human Behavior?

Executive Summary

The Centers for Medicare and Medicaid Services’ long awaited final rules on Accountable Care Organizations, issued on Oct. 20, include encouraging incentives for medication adherence. That’s good news for the industry, but it also throws a spotlight on the imperfect state of medication adherence methodologies.

You may also be interested in...



Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher

Value-based insurance design offers the promise of offering better quality care and helping to reduce costs, but getting there will require more than trying to influence behavior by reducing copayments, Harvard’s Choudhry said in a recent webinar.

ACO Success Depends On Optimal Medication Management – NPC

A recent article funded by the National Pharmaceutical Council asserts that the success of value-based health care delivery models such as accountable care organizations will require viewing pharmaceuticals as a tool that can reduce total costs and improve quality, rather than a siloed expense.

Medication Non-Adherence To Be Examined By Surgeon General

The HHS Office of the Surgeon General issues a request for information regarding the non-adherence of prescription medication. However, it is unclear how it plans to use the information once it is collected.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel